Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10941142 Formulations of a compound modulating kinases

Patent 10941142 was granted and assigned to Plexxikon Inc. on March, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Plexxikon Inc.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

109411420

Patent Inventor Names

Tomoari Kamo0

Gary Conard Visor0

Hamid Rezaei0

Hiroshi Yamakose0

Prabha N. Ibrahim0

Date of Patent

March 9, 2021

Patent Application Number

165107640

Date Filed

July 12, 2019

Patent Citations

‌

US Patent 10189833 Solid forms of a compound modulating kinases

‌

US Patent 10435404 Formulations of a compound modulating kinases

Patent Citations Received

‌

US Patent 12076322 Compounds and methods for kinase modulation, and indications therefor

‌

US Patent 11628176 Combinational drug therapies

Patent Primary Examiner

‌

Nizal S Chandrakumar

Patent abstract

Provided are compositions comprising Compound I having the following structure:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10941142 Formulations of a compound modulating kinases

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API